BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)
暂无分享,去创建一个
M. Hallek | S. Stilgenbauer | K. Kreuzer | M. Kneba | M. Ritgen | H. Hebart | J. Bahlo | K. Fischer | P. Cramer | S. Robrecht | O. Al-Sawaf | A. Engelke | T. Seiler | A. Fink | C. Wendtner | B. Eichhorst | J. Tresckow | L. Weikersthal | J. Bahlo | P. Langerbeins